Age-related discoloration of enamel

Overview

Diagnosis

Management

Special Populations

Key Recommendations

References

Showing 100 most recent of 548 indexed papers.

1 Pfau M. Introducing Christine A. Curcio and Cynthia Owsley, the 2025 Recipients of the Proctor Medal. Investigative ophthalmology & visual science 2026. link 2 Sasaki M, Apte RS, Bastion MC, Cheung CY, Chakravarthy U, Chang A et al.. International Consensus and Guidelines on Diagnosing and Managing Pachydrusen from APVRS, AEEC, APOIS, AAPPO, and ARI. American journal of ophthalmology 2026. link 3 Sommer-Lind F, Subhi Y, Vergmann AS, Lövestam-Adrian M, Andersen N, Borrelli E et al.. Consensus on age-related macular degeneration course curricula for general ophthalmologists and non-ophthalmologist clinical staff: A Delphi study. Acta ophthalmologica 2026. link 4 Kumarasinghe APW, Leung L, Young D, Pugliese M, Trivedi A, Foster A. The Impact of Initiating the Older Adult Surgical Inpatient Service on the Quantity and Quality of Goals of Patient Care Documentation. Australasian journal on ageing 2026. link 5 Caglayan Duman N, Uzun A. Real-world data of verteporfin-related ocular adverse events: A disproportionality analysis. Photodiagnosis and photodynamic therapy 2026. link 6 Lakhani M, Kwan ATH, Kundapur D, Popovic MM, Damji KF, Hurley BR. Association of Anti-VEGF Therapy with Reported Ocular Adverse Events: A Global Pharmacovigilance Analysis. Ophthalmology. Retina 2026. link 7 Lishinsky-Fischer N, Jaskoll S, Kramer A, Grunin M, Elbaz-Hayoun S, Rinsky B et al.. Distinct Genetic Profiles Associated With Subretinal Drusenoid Deposits and Cardiovascular Risk in Age-Related Macular Degeneration. Translational vision science & technology 2026. link 8 Bommakanti N, Momenaei B, Wang KY, Regillo CD, Cohen MN, Kuriyan AE et al.. Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated with Reference Ranibizumab for Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, or Retinal Vein Occlusion. Current eye research 2026. link 9 Hasan N, Sadeghi E, Gandhi P, Vupparaboina SC, Du K, Eller AW et al.. Demography, clinical profile and risk of retinal vein occlusion among patients with age-related macular degeneration - a tertiary hospital based study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2026. link 10 Lee HG, Kim J, Jang CY, Shin M. Antisense Oligonucleotide Therapeutics Targeting Age-Related Diseases. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2026. link 11 Stuard Sambhariya W, Bowes Rickman C, D'Amore PA, Corradetti G, Hageman GS, Howell GR et al.. Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation. Progress in retinal and eye research 2026. link 12 Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I. Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study. Acta ophthalmologica 2026. link 13 Zhou Y, Liu C, Yin J, Zhao D, Xue F. From environmental exposure to retinal pathology: epidemiological and mechanistic insights into multi-metal driven ocular diseases. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2026. link 14 Iida T, Gomi F, Yasukawa T, Yamashiro K, Honda S, Maruko I et al.. Japanese clinical guidelines for neovascular age-related macular degeneration. Japanese journal of ophthalmology 2025. link 15 Capuano V, Semoun O, Combes A, Mehanna CJ, Oubraham H, Souied EH. [Diagnostic approach and treatment paradigm in atrophic age related macular degeneration: Recommendations of the France Macula Federation]. Journal francais d'ophtalmologie 2025. link 16 Babaker R, Alzimami L, Al Ameer A, Almutairi M, Alam Aldeen R, Alshatti H et al.. Risk factors for age-related macular degeneration: Updated systematic review and meta-analysis. Medicine 2025. link 17 Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E et al.. Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis. Acta ophthalmologica 2025. link 18 Chakravarthy U, Schwartz R, Guymer RH, Holz FG, Rachitskaya AV, Vujosevic S et al.. Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks Trial. American journal of ophthalmology 2025. link 19 Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA. Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis. Clinical & experimental ophthalmology 2025. link 20 Schmidt-Erfurth U, Mai J, Reiter GS, Riedl S, Vogl WD, Sadeghipour A et al.. Disease Activity and Therapeutic Response to Pegcetacoplan for Geographic Atrophy Identified by Deep Learning-Based Analysis of OCT. Ophthalmology 2025. link 21 Eichenbaum DA, Holekamp N, Khanani AM, Pieramici D, Hershberger V, Sheth V et al.. Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. American journal of ophthalmology 2025. link 22 Jaggi D, Berger LE, Zweifel S, Becker MD, Michels S, Stalder O et al.. Comparison of treatment routine using aflibercept: Strict vs. relaxed retreatment regimen (TOLERANT study)-A non-inferiority, randomized controlled trial. Acta ophthalmologica 2025. link 23 Chiang A, Davis M, Stevens W, Garg S, Sheidow T, Jones DL et al.. Visual Acuity and Quality of Life Outcomes With Pegcetacoplan Treatment: A Post Hoc Analysis From the OAKS and DERBY Trials. American journal of ophthalmology 2025. link 24 Shi N, Li J, Shang M, Zhang W, Xu K, Li Y et al.. Detection and Management of Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Noninvasive Retinal Images and Artificial Intelligence: Systematic Review. Journal of medical Internet research 2025. link 25 Chiang B, Chung YG, Prausnitz MR. Suprachoroidal Drug Delivery for VEGF Suppression in Wet AMD and Other Diseases With Choroidal Neovascularization. American journal of ophthalmology 2025. link 26 Sarvepalli SM, Kapoor I, Sarici K, Garg SJ, Hadziahmetovic M. Evaluating photodynamic therapy as an adjuvant treatment for neovascular AMD: A comprehensive meta-analysis. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2025. link 27 Deng Q, Kishimoto K, Sugiyama O, Miyake M, Tamura H. Automatic Extraction of Images for Prognostic Prediction Models in Age-Related Macular Degeneration. Studies in health technology and informatics 2025. link 28 Alshaikhsalama AM, Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E. GOUT AND RISK OF AGE-RELATED MACULAR DEGENERATION. Retina (Philadelphia, Pa.) 2025. link 29 Simon LS, Davis ML, Medunjanin D, Fanning L, Damonte JC, Hunt K et al.. National Experience of Technology-based Eye Care Services: A Comprehensive Ophthalmology Telemedicine Initiative. Ophthalmology 2025. link 30 Wang H, Ie A, Chan T, Yates W, Kalloniatis M, Tong J et al.. ChatGPT-4 for addressing patient-centred frequently asked questions in age-related macular degeneration clinical practice. Eye (London, England) 2025. link 31 Liu Z, Zadeh RS. Connecting generations: An integrative review of intergenerational technology programs and older adults' technology use. Gerontology & geriatrics education 2025. link 32 Korinihona T, Thompson F, Russell SG, Quigley R, Miller G, Sagigi B et al.. The prevalence of suboptimal prescribing of medication in First Nations older adults in the Torres Strait. Australasian journal on ageing 2025. link 33 Li C, Chen M, Lu Y. An assessment of anti-VEGF drugs safety based on real-world data: from popularity to spontaneous reporting in eudravigilance database. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025. link 34 Misson GP, Anderson SJ, Dunne MCM. Radial polarisation patterns identify macular damage: a machine learning approach. Clinical & experimental optometry 2025. link 35 Long H, Xiong Y, Liu H, Yang M, Liu T, Gong C et al.. IL-6 Exacerbates Oxidative Damage of RPE Cells by Indirectly Destabilizing the mRNA of DNA Repair Genes. Inflammation 2025. link 36 Alsoudi AF, Koo E, Wai K, Mruthyunjaya P, Rahimy E. Ocular Neovascular Conversion and Systemic Bleeding Complications in Patients with Age-Related Macular Degeneration on Anticoagulants. Ophthalmology 2025. link 37 Ashrafkhorasani M, Habibi A, Nittala MG, Yaseri M, Emamverdi M, Velaga SB et al.. Spectral-domain OCT characteristics of intraretinal hyper-reflective foci associated with age-related macular degeneration and diabetic retinopathy. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2025. link 38 Krieger J, Cox O, Flacke JP, Beilschmidt L, Mueller S, Maywald U et al.. Real-world therapy and persistence of patients with neovascular age-related macular degeneration and diabetic retinopathy or diabetic macular edema: a German claims data analysis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025. link 39 Wei B, Wei M, Huang H, Fan T, Zhang Z, Song X. Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Age-Related Diseases. Cell proliferation 2025. link 40 Galindo AM, Ohayon A, Hod K, Levin MF, Geffen N, Shulman S. Real-world evidence of long-term durability and efficacy of faricimab as an advanced treatment line for NVAMD and DME. International ophthalmology 2025. link 41 Le HM, Querques G, Guenoun S, El Ghazi D, Haddad WM, Mouallem A et al.. Acute intra ocular inflammation following intravitreal injections of faricimab: A multicentric case series. European journal of ophthalmology 2025. link 42 Chong DD, Maatouk CM, Markle J, Shaia JK, Singh RP, Talcott KE. Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2025. link 43 Zhang YZ, Huo DY, Liu Z, Li XD, Wang Z, Li W. Review on ginseng and its potential active substance G-Rg2 against age-related diseases: Traditional efficacy and mechanism. Journal of ethnopharmacology 2025. link 44 Mensah EO, Danyo EK, Asase RV. Exploring the effect of different diet types on ageing and age-related diseases. Nutrition (Burbank, Los Angeles County, Calif.) 2025. link 45 Hamedani AG, Willis AW, Ying GS. Self-reported Visual Difficulty, Age-related Eye Disease, and Neuropsychiatric Outcomes in Older Adults. Ophthalmic epidemiology 2025. link 46 Chen Z, Cheang I, Qu Q, Zhu X, Fu Y, Gao R et al.. Associations of serum uric acid-to-high density lipoprotein cholesterol ratio with age-related diseases and mortality among older population in the United States. Archives of gerontology and geriatrics 2025. link 47 Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, Lad E et al.. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. Retina (Philadelphia, Pa.) 2024. link 48 Trinh M, Cheung R, Duong A, Nivison-Smith L, Ly A. OCT Prognostic Biomarkers for Progression to Late Age-related Macular Degeneration: A Systematic Review and Meta-analysis. Ophthalmology. Retina 2024. link 49 Samacá-Samacá D, Hernández-Castillo C, Prieto-Pinto L, Rodríguez F, Sardi C, Ocampo H et al.. Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis. BMJ open ophthalmology 2024. link 50 Sunaga T, Maeda M, Saulle R, Ng SM, Sato MT, Hasegawa T et al.. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration. The Cochrane database of systematic reviews 2024. link 51 Kang C, Lo JE, Zhang H, Ng SM, Lin JC, Scott IU et al.. Artificial intelligence for diagnosing exudative age-related macular degeneration. The Cochrane database of systematic reviews 2024. link 52 Wu J, Zhang M, Sun X. Analysis of biofluid metabolomic profiles to the discovery of biomarkers in age-related macular degeneration. BMJ open ophthalmology 2024. link 53 Papadopoulos Z. The role of the cytokine TNF-α in choroidal neovascularization: a systematic review. Eye (London, England) 2024. link 54 Pai HL, Lin DP, Chang HH. Current updates for hyperuricemia and gout in age-related macular degeneration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024. link 55 Gupta U, Maatouk CM, Markle JC, Talcott KE, Singh RP, Rachitskaya AV. Characterizing the Journey of Geographic Atrophy Patients in Routine Ophthalmic Practice. Ophthalmic surgery, lasers & imaging retina 2024. link 56 Jansook P, Loftsson T, Stefánsson E. Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability. International journal of pharmaceutics 2024. link 57 Lee K, Park YM, Choi JK, Lee J. Impact of COVID-19 on ophthalmic medical access during successive waves: Demographics, disease factors, and wave locations. Clinical & experimental ophthalmology 2024. link 58 Rosenfeld PJ, Shen M, Trivizki O, Liu J, Herrera G, Hiya FE et al.. Rediscovering Age-Related Macular Degeneration with Swept-Source OCT Imaging: The 2022 Charles L. Schepens, MD, Lecture. Ophthalmology. Retina 2024. link 59 Fujita M, Sasada M, Iyoda T, Fukai F. Involvement of Matricellular Proteins in Cellular Senescence: Potential Therapeutic Targets for Age-Related Diseases. International journal of molecular sciences 2024. link 60 Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A. Geroscience and pathology: a new frontier in understanding age-related diseases. Pathology oncology research : POR 2024. link 61 Kalenda J, Kočvarová I. Enduring inequality: Long-term trends and factors in participation in adult education and learning among older adults. Gerontology & geriatrics education 2024. link 62 Lyu YX, Fu Q, Wilczok D, Ying K, King A, Antebi A et al.. Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity. Aging 2024. link 63 Rojas-Solé C, Pinilla-González V, Lillo-Moya J, González-Fernández T, Saso L, Rodrigo R. Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy. Redox report : communications in free radical research 2024. link 64 Chandrasekara CMN, Gemikonakli G, Mach J, Sang R, Anwer AG, Agha A et al.. Ageing and Polypharmacy in Mesenchymal Stromal Cells: Metabolic Impact Assessed by Hyperspectral Imaging of Autofluorescence. International journal of molecular sciences 2024. link 65 Mikkelsen K, Trapali M, Apostolopoulos V. Role of Vitamin B in Healthy Ageing and Disease. Sub-cellular biochemistry 2024. link 66 Feng J, Xie F, Wu Z, Wu Y. Age-related macular degeneration and cardiovascular disease in US population: an observational study. Acta cardiologica 2024. link 67 Emami-Naeini P, Garmo V, Boucher N, Fernando R, Menezes A. Maintenance of Vision Needed to Drive after Intravitreal Anti-VEGF Therapy in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema. Ophthalmology. Retina 2024. link 68 Yang TM, Huang WL, Yang CH, Yang CM, Ho TC, Chen TC et al.. Association between non-steroidal anti-inflammatory drug use and development of age-related macular degeneration-A 10-year retrospective cohort study. Journal of the Formosan Medical Association = Taiwan yi zhi 2024. link 69 Wu Y, Xie Y, Yuan Y, Xiong R, Hu Y, Ning K et al.. The Mediterranean Diet and Age-Related Eye Diseases: A Systematic Review. Nutrients 2023. link 70 Yao X, Yang H, Han H, Kou X, Jiang Y, Luo M et al.. Genome-wide analysis of genetic pleiotropy and causal genes across three age-related ocular disorders. Human genetics 2023. link 71 Baumal CR, Sørensen TL, Karcher H, Freitas RL, Becher A, Balez S et al.. Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies. Acta ophthalmologica 2023. link 72 Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC et al.. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology 2023. link 73 Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. The Cochrane database of systematic reviews 2023. link 74 Cheong KX, Cheung CMG, Teo KYC. Review of Fibrosis in Neovascular Age-Related Macular Degeneration. American journal of ophthalmology 2023. link 75 Gomes DF, Curado DDSP, Gomes RM, Leite BF, Ramos MC, Silva END. Clinical effectiveness of screening for age-related macular degeneration: A systematic review. PloS one 2023. link 76 Budnik A, Palewski M, Michnowska-Kobylińska M, Lisowski Ł, Łapińska M, Stachurska Z et al.. The prevalence of age-related macular degeneration and osteoporosis in the older Polish population: Is there a link?. PloS one 2023. link 77 Bora PS. New Discoveries in Retinal Cell Degeneration and Retinal Diseases. Biomolecules 2023. link 78 Haj Najeeb B, Schmidt-Erfurth U. Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?. Eye (London, England) 2023. link 79 Stanford P. Age-related macular degeneration: care of the patient in the community setting. British journal of community nursing 2023. link 80 Kang C. Avacincaptad Pegol: First Approval. Drugs 2023. link 81 Trivizki O, Loewenstein A, Zur D. The roadmap to geographic atrophy treatment: A journey of trials and promise. Acta ophthalmologica 2023. link 82 Lo Faro V. Answer to the Hamlet-like dilemma of lipid metabolites causing senile macular degeneration. Cell reports. Medicine 2023. link 83 Dalvi S, Chatterjee A, Singh R. AMD recapitulated in a 3D biomimetic: A breakthrough in retina tissue engineering. Cell stem cell 2023. link 84 Faes L, Maloca PM, Hatz K, Wolfensberger TJ, Munk MR, Sim DA et al.. Transforming ophthalmology in the digital century-new care models with added value for patients. Eye (London, England) 2023. link 85 Gallivan MD, Garcia KM, Torres AZ, Lum F, Li C, Mbagwu M et al.. Emulating VIEW 1 and VIEW 2 Clinical Trial Outcome Data Using the American Academy of Ophthalmology IRIS Registry. Ophthalmic surgery, lasers & imaging retina 2023. link 86 Cannon M, Kerwood R, Ramon M, Rowley SJ, Rubio H. Laying the groundwork for an Age-Friendly University: A multi-method case study. Gerontology & geriatrics education 2023. link 87 Campbell S, Dewhurst E, Chaudry A, Edson R, Ghafoor R, Greenhalgh M et al.. Gerontology, Art, and Activism: Can the Intersection of Art, Social Research, and Community Power Lead to Lasting Change?. The Gerontologist 2023. link 88 Farah KS, Montepare JM. Unusual suspects for Age-Friendly University (AFU) intergenerational classroom exchange: A classroom case study in forensic science. Gerontology & geriatrics education 2023. link 89 Komarova TM, Vitovska OP, Komisarenko YI, Scholtz SK. VITAMIN D LEVEL AND ITS LINK WITH VISUAL ACUITY AND CONTRAST SENSITIVITY IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION. Wiadomosci lekarskie (Warsaw, Poland : 1960) 2023. link 90 Lally DR, Loewenstein A, Arnold JJ, Yang YC, Gedif K, Best C et al.. Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies. Eye (London, England) 2023. link 91 Bhandari S, Nguyen V, Hunt A, Gabrielle PH, Viola F, Mehta H et al.. Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion. Eye (London, England) 2023. link 92 Weinstein O, Kridin M, Kridin K, Mann O, Cohen AD, Zloto O. The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study. Eye (London, England) 2023. link 93 Warwick AN, Curran K, Hamill B, Stuart K, Khawaja AP, Foster PJ et al.. UK Biobank retinal imaging grading: methodology, baseline characteristics and findings for common ocular diseases. Eye (London, England) 2023. link 94 Ahluwalia A, Shen LL, Bao Y, Sun M, Young BK, Park MM et al.. The influence of the topographic location of geographic atrophy on vision-related quality of life in nonexudative age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2023. link 95 Ryou IS, Lee SW, Mun H, Lee JK, Chun S, Cho K. Trend of incidence rate of age-related diseases: results from the National Health Insurance Service-National Sample Cohort (NHIS-NSC) database in Korea: a cross- sectional study. BMC geriatrics 2023. link 96 Forshaw TRJ, Subhi Y, Andréasson S, Sørensen TL. Full-Field Electroretinography Changes Associated with Age-Related Macular Degeneration: A Systematic Review with Meta-Analyses. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2022. link 97 Maesa JM, Baños-Álvarez E, Rosario-Lozano MP, Blasco-Amaro JA. Diagnostic accuracy of optical coherence tomography angiography in the detection of neovasculature in age-related macular degeneration: a meta-analysis. Acta ophthalmologica 2022. link 98 Chen Z, Zeng Y, Tian F. Effect of cataract surgery on the progression of age-related macular degeneration. Medicine 2022. link 99 Mauschitz MM, Schmitz MT, Verzijden T, Schmid M, Thee EF, Colijn JM et al.. Physical Activity, Incidence, and Progression of Age-Related Macular Degeneration: A Multicohort Study. American journal of ophthalmology 2022. link 100 Sia JT, Lee EPX, Cheung CMG, Fenwick EK, Laude A, Ho KC et al.. Associations between age-related macular degeneration and sleep dysfunction: A systematic review. Clinical & experimental ophthalmology 2022. link